Koers Kadimastem Ltd TEL AVIV STOCK EXCHANGE
Aandelen
KDST
IL0011284614
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 24,87 mln. 94,67 mln. 23,26 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -22 mln. -83,75 mln. -20,58 mln. | Nettowinst (verlies) 2023 | -12 mln. -45,68 mln. -11,22 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 739K 2,81 mln. 691K | Nettoschuld 2023 | 2,17 mln. 8,26 mln. 2,03 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,76
x | K/w-verhouding 2023 |
-2,09
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 39,92% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Asaf Shiloni
CEO | Chief Executive Officer | 54 | 01-02-21 |
Michel Revel
FOU | Founder | 85 | 06-10-08 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 14-06-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | 17-12-20 | |
Tamar Galili
BRD | Director/Board Member | 51 | 03-01-22 |
Ronen Twito
CHM | Chairman | 49 | 23-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |